Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluate efficacy and safety of prophylactic antibiotics in preventing early ventilator-associated pneumonia
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| B.lactam | Active Comparator | Patient recieved beta lactam iv 1gm each 12h for 2 days |
|
| Control group | Placebo Comparator | patients in the control group will receive saline iv each 12h for 2 days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Beta Lactam Antibiotics | Drug | Beta lactam cefipim infusion (20mg/kg -12h -2 days ) total volume 10 ml |
|
| Measure | Description | Time Frame |
|---|---|---|
| Ventilation associated pneumonia | The primary outcome is the proportion of patients who will develop VAP (radiology, TLC, temperature, hemodynamic, sputum culture )from the 2nd to the 7th day of mechanical ventilation | from the 2nd to the 7th day of mechanical ventilation |
Not provided
Not provided
Inclusion Criteria:
• Age > 18 years or older
Exclusion Criteria:
ongoing pneumonia or gross aspiration confirmed by the presence of lung infiltrates on chest radiographs at admission before invasive ventilation
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Benha university hospital | Banhā | Al-Qalyubia | 13511 | Egypt |
Not provided
Efficacy of prophylactic antibiotic against vent.associated pneumonia
Not provided
Not provided
Not provided
| Salin | Drug | Patient will receive .9 % saline (10ml /12h/2days) |
|
|
| ID | Term |
|---|---|
| D053717 | Pneumonia, Ventilator-Associated |
| ID | Term |
|---|---|
| D000077299 | Healthcare-Associated Pneumonia |
| D003428 | Cross Infection |
| D007239 | Infections |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D007049 | Iatrogenic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000097902 | beta Lactam Antibiotics |
| ID | Term |
|---|---|
| D000900 | Anti-Bacterial Agents |
| D000890 | Anti-Infective Agents |
| D045506 | Therapeutic Uses |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
Not provided
Not provided